Dr. Bo Ying of Abogen Biosciences to Present mRNA Therapeutics Advancements at 4th mRNA-Based Therapeutics Summit Europe

Abogen CEO to Attend mRNA Therapeutics Summit in Europe

Founder, Chairman and Chief Executive Officer of Abogen (CEO) Dr. Abogen will be at2025Year1Attended the "4thmRNATherapy Summit (Europe)"4th mRNA-Based Therapeutics Summit Europe"）。AsCEO&Global Leader Think Tank (CEO & Global Leaders Think Tank) Guest, he will join other international guests on the first day of the conference.mRNAPharmaceutical CompanyCEOand well-known biopharmaceutical companiesGlobal LeaderLooking Forward TogethermRNAThe Future Development and Prospects of Therapy, and Will Be inPlenary Session (Plenary Session）IntroductionmRNALatest Clinical Advances in Therapeutic Cancer Vaccines。

Figure 1: AbogenCEODr. Abogen

AsmRNAA globally renowned industry summit in the field of drug research and development,“mRNATherapy Summit”Has been held for several consecutive sessions. The theme of this summit is "Leading the Next GenerationmRNA"A New Era of Drugs Moving Towards Clinical Application" ("Revolutionising the Next Wave of mRNA Medicines Towards Clinical Reality"），Will converge40Multiple representatives from globally renowned pharmaceutical companies (Moderna、BioNTech、CureVac、GSK、Sanofi, and other heavyweight speakers,Joint DiscussionmRNALatest Advances and Future Trends in Therapy.It is expected that200Multiple GlobalmRNAField ofIndustry experts, scholars, and corporate representatives attended the meeting.

Figure 2: The FourthmRNATherapy Summit (Europe)

Introduction to the Sharing Session by Abogen's CEO

Dr. Abogen will mainly share in the following two aspects:

1.    General Assembly

Time:2025Year1Month30Date: Morning8:30

Subject:BeyondCOVID-19Vaccine'smRNATreatment Technology and Clinical Advances (Technical & Clinical Progress in mRNA Therapeutics Beyond COVID-19 Vaccine）

Content Overview:Will showcase how Abogen utilizes its leadingmRNAAnd nano-delivery technology platform, promotingmRNADevelopment of Tumor Therapeutic Vaccines and SharingmRNAThe Vision of Future Treatment.

2.    CEO&Global Leader Think Tank

Time:2025Year1Month29Date: Morning8:25

Subject:StartmRNAA New Era of Vaccines and Therapeutics: Accelerating the Delivery of High-Quality Drugs to Patients (Unlocking the Next Frontiers of mRNA-Based Vaccines & Therapeutics to Ensure Better Drugs Reach Patients Faster）

Content Overview:Will collaborate withCureVac、Mercurna、Pantherna TherapeuticsWorld-renownedmRNAPharmaceutical CompanyCEO andWell-known biopharmaceutical companySanofiGlobal leaders gather on the same stage to jointly discussmRNAIn the development blueprint of the treatment field and the industry's direction.

Abogen, as a pioneer in the industry,Gaining international attention and recognition

The agenda of the conference shows,2024Globally launched in49ItemmRNAClinical trials of vaccines and therapies mark a significant step forward.COVID-19A new era of treatment. It is worth mentioning that,Abogen will collaborate withCureVac、Ethris and University College LondonSharing the First-in-Human Clinical Study at the Conference (First-in-Human trial) New Progress,Known as "an unmissable link" ("SESSIONS YOU CANNOT MISS"）。

For more information about the conference, please visit the official website:http://www.mrnabased-therapeutics-europe.com/。

About Us

Abogen Biosciences Co., Ltd. ("Abogen") is an innovative biopharmaceutical company focused on the research and development of messenger ribonucleic acid (mRNA) drugs. The company owns industry-leading, proprietary technology platforms in mRNA and nanodelivery, and is one of the few mRNA drug R&D enterprises in China with complete value chain capabilities, covering all aspects from mRNA design, formulation development to large-scale production. The company has established a rich product pipeline, spanning multiple fields including infectious disease prevention and control (such as the mRNA COVID-19 vaccine), cancer immunotherapy, and protein replacement therapy.